Characterization of the Burkholderia cenocepacia TonB mutant as a potential live attenuated vaccine

Gonzalo A. Pradenas, Julia N. Myers, Alfredo Torres

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Burkholderia cenocepacia is an opportunistic pathogen prevalent in cystic fibrosis patients, which is particularly difficult to treat, causing chronic and eventually fatal infections. The lack of effective treatment options makes evident the need to develop alternative therapeutic or prophylactic approaches. Vaccines, and live attenuated vaccines, are an unexplored avenue to treat B. cenocepacia infections. Here we constructed and characterized a B. cenocepacia tonB mutant strain, which was unable to actively transport iron, to test whether this single gene deletion mutant (strain renamed GAP001) protected against an acute respiratory B. cenocepacia lethal infection. Here we show that the mutant strain GAP001 is attenuated, and effective at protecting against B. cenocepacia challenge. Intranasal administration of GAP001 to BALB/c mice resulted in almost complete survival with high degree of bacterial clearance.

Original languageEnglish (US)
Article number33
JournalVaccines
Volume5
Issue number4
DOIs
StatePublished - Dec 1 2017

Fingerprint

Burkholderia cenocepacia
Attenuated Vaccines
Burkholderia Infections
Intranasal Administration
Gene Deletion
Infection
Cystic Fibrosis
Iron
Survival
Therapeutics

Keywords

  • Attenuated strain
  • Burkholderia cenocepacia
  • TonB
  • Vaccine

ASJC Scopus subject areas

  • Immunology
  • Pharmacology
  • Drug Discovery
  • Infectious Diseases
  • Pharmacology (medical)

Cite this

Characterization of the Burkholderia cenocepacia TonB mutant as a potential live attenuated vaccine. / Pradenas, Gonzalo A.; Myers, Julia N.; Torres, Alfredo.

In: Vaccines, Vol. 5, No. 4, 33, 01.12.2017.

Research output: Contribution to journalArticle

@article{73a4649284b343bb8a4cd80b46551923,
title = "Characterization of the Burkholderia cenocepacia TonB mutant as a potential live attenuated vaccine",
abstract = "Burkholderia cenocepacia is an opportunistic pathogen prevalent in cystic fibrosis patients, which is particularly difficult to treat, causing chronic and eventually fatal infections. The lack of effective treatment options makes evident the need to develop alternative therapeutic or prophylactic approaches. Vaccines, and live attenuated vaccines, are an unexplored avenue to treat B. cenocepacia infections. Here we constructed and characterized a B. cenocepacia tonB mutant strain, which was unable to actively transport iron, to test whether this single gene deletion mutant (strain renamed GAP001) protected against an acute respiratory B. cenocepacia lethal infection. Here we show that the mutant strain GAP001 is attenuated, and effective at protecting against B. cenocepacia challenge. Intranasal administration of GAP001 to BALB/c mice resulted in almost complete survival with high degree of bacterial clearance.",
keywords = "Attenuated strain, Burkholderia cenocepacia, TonB, Vaccine",
author = "Pradenas, {Gonzalo A.} and Myers, {Julia N.} and Alfredo Torres",
year = "2017",
month = "12",
day = "1",
doi = "10.3390/vaccines5040033",
language = "English (US)",
volume = "5",
journal = "Vaccines",
issn = "2076-393X",
publisher = "Multidisciplinary Digital Publishing Institute (MDPI)",
number = "4",

}

TY - JOUR

T1 - Characterization of the Burkholderia cenocepacia TonB mutant as a potential live attenuated vaccine

AU - Pradenas, Gonzalo A.

AU - Myers, Julia N.

AU - Torres, Alfredo

PY - 2017/12/1

Y1 - 2017/12/1

N2 - Burkholderia cenocepacia is an opportunistic pathogen prevalent in cystic fibrosis patients, which is particularly difficult to treat, causing chronic and eventually fatal infections. The lack of effective treatment options makes evident the need to develop alternative therapeutic or prophylactic approaches. Vaccines, and live attenuated vaccines, are an unexplored avenue to treat B. cenocepacia infections. Here we constructed and characterized a B. cenocepacia tonB mutant strain, which was unable to actively transport iron, to test whether this single gene deletion mutant (strain renamed GAP001) protected against an acute respiratory B. cenocepacia lethal infection. Here we show that the mutant strain GAP001 is attenuated, and effective at protecting against B. cenocepacia challenge. Intranasal administration of GAP001 to BALB/c mice resulted in almost complete survival with high degree of bacterial clearance.

AB - Burkholderia cenocepacia is an opportunistic pathogen prevalent in cystic fibrosis patients, which is particularly difficult to treat, causing chronic and eventually fatal infections. The lack of effective treatment options makes evident the need to develop alternative therapeutic or prophylactic approaches. Vaccines, and live attenuated vaccines, are an unexplored avenue to treat B. cenocepacia infections. Here we constructed and characterized a B. cenocepacia tonB mutant strain, which was unable to actively transport iron, to test whether this single gene deletion mutant (strain renamed GAP001) protected against an acute respiratory B. cenocepacia lethal infection. Here we show that the mutant strain GAP001 is attenuated, and effective at protecting against B. cenocepacia challenge. Intranasal administration of GAP001 to BALB/c mice resulted in almost complete survival with high degree of bacterial clearance.

KW - Attenuated strain

KW - Burkholderia cenocepacia

KW - TonB

KW - Vaccine

UR - http://www.scopus.com/inward/record.url?scp=85031118709&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85031118709&partnerID=8YFLogxK

U2 - 10.3390/vaccines5040033

DO - 10.3390/vaccines5040033

M3 - Article

AN - SCOPUS:85031118709

VL - 5

JO - Vaccines

JF - Vaccines

SN - 2076-393X

IS - 4

M1 - 33

ER -